Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2011 Jul-Sep;26(3):133-9.

Effect of prior medical treatments on ischemic stroke severity and outcome

Simona Sacco  1 , Danilo Toni, Angelo A Bignamini, Augusto Zaninelli, Gian Franco Gensini, Antonio Carolei; SIRIO Study Group
Affiliations
Multicenter Study

Effect of prior medical treatments on ischemic stroke severity and outcome

Simona Sacco et al. Funct Neurol. 2011 Jul-Sep.

Abstract

Antiplatelets, antihypertensives, and statins might reduce the severity of the event or improve outcome in patients who, despite prior medical treatment, have a stroke. We evaluated, in patients who had an ischemic stroke, the effect, on stroke severity and outcome, of prior treatment with antiplatelets, antihypertensives, and statins, used either alone or in a three-drug combination. Stroke in Italy and Related Impact on Outcome (SIRIO) was a prospective, nationwide, multicenter, hospital-based, observational study that included patients aged.18 years with acute ischemic stroke. We studied 2,529 acute ischemic stroke patients from the SIRIO population: 887 were antiplatelet users, 1,497 antihypertensive users, 231 statin users, and 138 three-drug combination users prior to the index event. The adjusted logistic regression analysis showed an association between prior treatment with statins and good functional outcome at discharge, while prior treatment with antiplatelets, antihypertensives or the three-drug combination did not influence severity or outcome. The absolute probability of a good functional outcome was 46.3% (95% CI: 40.3%-53.2%) in statin users and 36.7% (95% CI: 34.7%-38.7%) in non-users of statins; the absolute risk difference was 9.6% (95% CI: 2.9%-16.4%; p=0.004). Prior treatment with antiplatelets, antihypertensives, or the three-drug combination did not influence stroke severity or outcome, while prior treatment with statins did not influence stroke severity but was associated with a better functional outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Logistic regression analysis of the probability of a mild stroke on admission (National Institutes of Stroke Scale score <8 on admission) and a good functional outcome at discharge (modified Rankin Scale score <2 at discharge), adjusted for age, gender, and risk factors, and referring to mRS score at discharge also adjusted for baseline NIHSS.
Figure 2
Figure 2
Proportions of statin users and non-users according to the modified Rankin Scale (mRS) score at discharge.
See this image and copyright information in PMC

References

    1. Sacco RL , Adams R , Albers G , et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline . Stroke . 2006 ; 37 : 577 – 617 . - PubMed
    1. Alvarez-Sabín J , Huertas R , Quintana M , et al. Prior statin use may be associated with improved stroke outcome after tissue plasminogen activator . Stroke . 2007 ; 38 : 1076 – 1078 . - PubMed
    1. Arboix A , García-Eroles L , Oliveres M , Targa C , Balcells M , Massons J . Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? . BMC Neurol . 2010 ; 10 : 47 . - PMC - PubMed
    1. Deplanque D , Masse I , Lefebvre C , Libersa C , Leys D , Bordet R . Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity . Neurology . 2006 ; 67 : 1403 – 1410 . - PubMed
    1. Goldstein LB , Amarenco P , Zivin J , et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial . Stroke . 2009 ; 40 : 3526 – 3531 . - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources